As CAR-T Therapies Move Into Earlier Lines, Best Uses Begin To Come Into Focus

Yescarta, Breyanzi Second-Line LBCL Approvals Expected Soon

 
• By Mandy Jackson
Double escalator going up
CAR-T therapies are moving up from third-line or later into second-line and earlier settings • Source: Alamy

More from Clinical Trials

More from R&D